Steven Cohen Pacira Bio Sciences, Inc. Transaction History

Point72 Asset Management, L.P.

$42.2 Billion
Q4 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,075,673 shares of PCRX stock, worth $27.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,075,673

Holding current value

$27.1 Million

% of portfolio

0.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$15.3 - $20.33 $16.5 Million - $21.9 Million	1,075,673 New	1,075,673 $20.3 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $18,776 - $24,535	612 Added 145.71%	1,032 $31,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $17.3 Million - $22.7 Million	-478,796 Reduced 99.91%	420 $16,000
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $17 Million - $20.8 Million	479,216 New	479,216 $19.6 Million
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $873,129 - $1.56 Million	-30,744 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $10.9 Million - $14.1 Million	-300,035 Reduced 90.71%	30,744 $1.39 Million
Q3 2019 Nov 15, 2019	SELL	$35.66 - $44.99 $29.7 Million - $37.5 Million	-833,862 Reduced 71.6%	330,779 $12.6 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $19.4 Million - $25.5 Million	531,059 Added 83.82%	1,164,641 $50.7 Million
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $875,899 - $1.01 Million	24,017 Added 3.94%	633,582 $24.1 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $15.3 Million - $19.4 Million	371,169 Added 155.69%	609,565 $26.2 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $4.49 Million - $7.11 Million	136,760 Added 134.56%	238,396 $11.7 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $2.47 Million - $3.58 Million	89,936 Added 768.68%	101,636 $3.26 Million
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $14.7 Million - $22.7 Million	-489,300 Reduced 97.66%	11,700 $364,000
Q4 2017 Feb 14, 2018	SELL	$31.85 - $46.95 $18.6 Million - $27.4 Million	-583,886 Reduced 53.82%	501,000 $22.9 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $38.7 Million - $42.9 Million	1,084,886	1,084,886 $40.7 Million

Others Institutions Holding PCRX

# of Institutions

260

Shares Held

49.8M

Call Options Held

1.03M

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.15B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account